Krystal Biotech, Inc. (KRYS)

Healthcare · Biotechnology · NASDAQ

Krystal Biotech, Inc. (KRYS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $9.66B, a trailing price-to-earnings ratio of 40.9 and a free-cash-flow yield of 1.9%. Over the most recent reported fiscal year, revenue grew 33.9% and free cash flow per share grew 57.4%.

Market cap	$9.66B
Trailing P/E	40.9
FCF yield	1.9%
Revenue growth (YoY)	+33.9%
EPS growth (YoY)	+62.7%
FCF/share growth (YoY)	+57.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live KRYS data on Nama Insights →

Recent Congressional trades

Krystal Biotech, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Christopher L. Jacobs	House	Buy	$1,001 - $15,000	Jan 10, 2023